Who owns Carmell Therapeutics Corp - US?
- Ticker: XAGEW
- CUSIP Number: 142922111
Tip: Access positions for across all investors
Analyze quarterly positions in Carmell Therapeutics Corp - US with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Carmell Therapeutics Corp - US stock
Who bought or sold Carmell Therapeutics Corp - US this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Clear Street | 13k | $401.340800 | -2% | Jun 2025 |
|
| Ancora Advisors | 2.8k | $42.981400 | 0% | Sep 2025 |
|
Who sold out of Carmell Therapeutics Corp - US?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| UBS O'Connor | Jun 2025 | 371k | $11k |
| Linden Advisors | Jun 2025 | 371k | $9.9k |
| Toronto-Dominion Bank | Jun 2025 | 365k | $11k |
| Balyasny Asset Management | Jun 2025 | 343k | $8.0k |
| OZ Management | Jun 2025 | 228k | $6.1k |
| Millennium Management | Jun 2025 | 189k | $5.7k |
| CNH Partners | Jun 2025 | 46k | $1.1k |
| Citadel Advisors | Jun 2025 | 44k | $1.0k |
| Saba Capital Management | Jun 2025 | 20k | $525.387200 |